Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Anika Therapeutics (ANIK) Other Non-Current Liabilities (2016 - 2025)

Historic Other Non-Current Liabilities for Anika Therapeutics (ANIK) over the last 16 years, with Q3 2025 value amounting to $761000.0.

  • Anika Therapeutics' Other Non-Current Liabilities fell 558.31% to $761000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $761000.0, marking a year-over-year decrease of 558.31%. This contributed to the annual value of $772000.0 for FY2024, which is 9108.91% up from last year.
  • Latest data reveals that Anika Therapeutics reported Other Non-Current Liabilities of $761000.0 as of Q3 2025, which was down 558.31% from $756000.0 recorded in Q2 2025.
  • In the past 5 years, Anika Therapeutics' Other Non-Current Liabilities ranged from a high of $16.9 million in Q2 2021 and a low of $398000.0 during Q4 2022
  • Moreover, its 5-year median value for Other Non-Current Liabilities was $684000.0 (2022), whereas its average is $1.8 million.
  • Per our database at Business Quant, Anika Therapeutics' Other Non-Current Liabilities plummeted by 9652.66% in 2022 and then skyrocketed by 10150.0% in 2024.
  • Anika Therapeutics' Other Non-Current Liabilities (Quarter) stood at $1.3 million in 2021, then crashed by 68.36% to $398000.0 in 2022, then rose by 1.51% to $404000.0 in 2023, then surged by 91.09% to $772000.0 in 2024, then dropped by 1.42% to $761000.0 in 2025.
  • Its Other Non-Current Liabilities was $761000.0 in Q3 2025, compared to $756000.0 in Q2 2025 and $744000.0 in Q1 2025.